Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study.

Liu WJ, Sesay FR, Coursier A, Knust B, Marrinan JE, Whitmer S, McDonald SLR, Gaillard P, Liu Y, Su Q, Zhang Y, Crozier I, Ariyarajah A, Carino M, Massaquoi T, Broutet N, Xu W, Wu G, Ströher U, Gao GF, Formenty P, Sahr F, Deen GF; Sierra Leone Ebola Virus Persistence Study Group .

Open Forum Infect Dis. 2019 Feb 26;6(3):ofz068. doi: 10.1093/ofid/ofz068. eCollection 2019 Mar.

2.

Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned.

Deen GF, McDonald SLR, Marrinan JE, Sesay FR, Ervin E, Thorson AE, Xu W, Ströher U, Ongpin P, Abad N, Ariyarajah A, Malik T, Liu H, Ross C, Durski KN, Gaillard P, Morgan O, Formenty P, Knust B, Broutet N, Sahr F; Sierra Leone Ebola Virus Persistence Study Group.

PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005723. doi: 10.1371/journal.pntd.0005723. eCollection 2017 Sep.

3.

Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016.

Abad N, Malik T, Ariyarajah A, Ongpin P, Hogben M, McDonald SLR, Marrinan J, Massaquoi T, Thorson A, Ervin E, Bernstein K, Ross C, Liu WJ, Kroeger K, Durski KN, Broutet N, Knust B, Deen GF; Sierra Leone Ebola Virus Persistence Study Group.

PLoS Negl Trop Dis. 2017 Sep 11;11(9):e0005827. doi: 10.1371/journal.pntd.0005827. eCollection 2017 Sep.

4.

Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report.

Deen GF, Broutet N, Xu W, Knust B, Sesay FR, McDonald SLR, Ervin E, Marrinan JE, Gaillard P, Habib N, Liu H, Liu W, Thorson AE, Yamba F, Massaquoi TA, James F, Ariyarajah A, Ross C, Bernstein K, Coursier A, Klena J, Carino M, Wurie AH, Zhang Y, Dumbuya MS, Abad N, Idriss B, Wi T, Bennett SD, Davies T, Ebrahim FK, Meites E, Naidoo D, Smith SJ, Ongpin P, Malik T, Banerjee A, Erickson BR, Liu Y, Liu Y, Xu K, Brault A, Durski KN, Winter J, Sealy T, Nichol ST, Lamunu M, Bangura J, Landoulsi S, Jambai A, Morgan O, Wu G, Liang M, Su Q, Lan Y, Hao Y, Formenty P, Ströher U, Sahr F.

N Engl J Med. 2017 Oct 12;377(15):1428-1437. doi: 10.1056/NEJMoa1511410. Epub 2015 Oct 14.

5.

Impact of temozolomide on immune response during malignant glioma chemotherapy.

Sengupta S, Marrinan J, Frishman C, Sampath P.

Clin Dev Immunol. 2012;2012:831090. doi: 10.1155/2012/831090. Epub 2012 Oct 24. Review.

6.

Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.

Douglas CM, D'Ippolito JA, Shei GJ, Meinz M, Onishi J, Marrinan JA, Li W, Abruzzo GK, Flattery A, Bartizal K, Mitchell A, Kurtz MB.

Antimicrob Agents Chemother. 1997 Nov;41(11):2471-9.

7.

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.

Kurtz MB, Abruzzo G, Flattery A, Bartizal K, Marrinan JA, Li W, Milligan J, Nollstadt K, Douglas CM.

Infect Immun. 1996 Aug;64(8):3244-51.

8.

Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.

Kurtz MB, Bernard EM, Edwards FF, Marrinan JA, Dropinski J, Douglas CM, Armstrong D.

Antimicrob Agents Chemother. 1995 Aug;39(8):1784-9.

9.

The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase.

Douglas CM, Foor F, Marrinan JA, Morin N, Nielsen JB, Dahl AM, Mazur P, Baginsky W, Li W, el-Sherbeini M, et al.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12907-11.

10.

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

Kurtz MB, Douglas C, Marrinan J, Nollstadt K, Onishi J, Dreikorn S, Milligan J, Mandala S, Thompson J, Balkovec JM, et al.

Antimicrob Agents Chemother. 1994 Dec;38(12):2750-7.

11.

A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase.

Douglas CM, Marrinan JA, Li W, Kurtz MB.

J Bacteriol. 1994 Sep;176(18):5686-96.

12.

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase.

Kurtz MB, Heath IB, Marrinan J, Dreikorn S, Onishi J, Douglas C.

Antimicrob Agents Chemother. 1994 Jul;38(7):1480-9. Erratum in: Antimicrob Agents Chemother 1994 Oct;38(10):2516.

13.

Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives.

Bouffard FA, Zambias RA, Dropinski JF, Balkovec JM, Hammond ML, Abruzzo GK, Bartizal KF, Marrinan JA, Kurtz MB, McFadden DC, et al.

J Med Chem. 1994 Jan 21;37(2):222-5. No abstract available.

PMID:
8295208
14.

Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii.

Horn WS, Smith JL, Bills GF, Raghoobar SL, Helms GL, Kurtz MB, Marrinan JA, Frommer BR, Thornton RA, Mandala SM.

J Antibiot (Tokyo). 1992 Oct;45(10):1692-6. No abstract available.

15.

Cloning and characterization of the plasma membrane H(+)-ATPase from Candida albicans.

Monk BC, Kurtz MB, Marrinan JA, Perlin DS.

J Bacteriol. 1991 Nov;173(21):6826-36.

16.

Isolation of hem3 mutants from Candida albicans by sequential gene disruption.

Kurtz MB, Marrinan J.

Mol Gen Genet. 1989 May;217(1):47-52.

PMID:
2671651
17.

Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive site.

Bock SC, Marrinan JA, Radziejewska E.

Biochemistry. 1988 Aug 9;27(16):6171-8. Erratum in: Biochemistry 1989 Apr 18;28(8):3628.

PMID:
3191114
18.

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.

Bock SC, Skriver K, Nielsen E, Thøgersen HC, Wiman B, Donaldson VH, Eddy RL, Marrinan J, Radziejewska E, Huber R, et al.

Biochemistry. 1986 Jul 29;25(15):4292-301.

PMID:
3756141
19.

Eight PHS hospitals threatened with early closure.

Marrinan J.

Health Law Vigil. 1981 Jul 24;4(15):8-9. No abstract available.

PMID:
10252303
20.

HHS evaluation leads to defunding of 46 PSROs...

Marrinan J.

Health Law Vigil. 1981 Jun 26;4(13):4-5. No abstract available.

PMID:
10273265
21.

PPI regulations put on hold; HHS is sued by consumer groups.

Aardsma AH, Marrinan J.

Health Law Vigil. 1981 Apr 17;4(8):7-8. No abstract available.

PMID:
10250673
22.

AHR comment period ends: congressional analysis begins.

Marrinan J, Goldberg L.

Health Law Vigil. 1980 Jun 13;3(12):3-4. No abstract available.

PMID:
10246810

Supplemental Content

Loading ...
Support Center